Kymriah Injection, Suspension
Product Images NDC 0078-0958

3 FDA label images from Novartis Pharmaceuticals Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Kymriah (NDC 0078-0958). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Note: The Patient Identifier Number May Be Preceded By The Letters Din Or Aph Id. (Kymriah 01)

Note: The Patient Identifier Number May Be Preceded By The Letters Din Or Aph Id. (Kymriah 01)
Illustration showing a labeled bag for KYMRIAH (tisagenlecleucel) cellular therapy injection, suspension for intravenous use. The image highlights the label area with patient information fields including Name, Date of Birth, DIN or Aph ID, Expiry Date, Batch number, and Material numbers. The bag is marked with the Novartis logo.*
FDA Label Image

Principal Display Paneltisagenlecleucelkymriahtmndc 0078-0846-19human T Cellsrx Only Suspension For Iv Infusioncultured, Genetically Modifiedfor Autologous Use Onlydispense With Medication Guidenovartis (Kymriah 02)

Principal Display Paneltisagenlecleucelkymriahtmndc 0078-0846-19human T Cellsrx Only Suspension For Iv Infusioncultured, Genetically Modifiedfor Autologous Use Onlydispense With Medication Guidenovartis (Kymriah 02)
Label for KYMRIAH injection, suspension containing tisagenlecleucel, a cellular therapy for intravenous infusion. The label indicates it contains cultured, genetically modified human T cells for autologous use only. It lists storage instructions at or below -120°C and manufacturer as Novartis Pharmaceuticals Corporation, Morris Plains, NJ. Dosage and preparation details are included, along with a barcode and contact information.*
FDA Label Image

Kymriah 03

Kymriah 03
Label for KYMRIAH (tisagenlecleucel) injection, suspension for intravenous infusion. The label describes it as a human T cell suspension, genetically modified for autologous use only. It includes dosage form details, storage instructions at or below -120°C, manufacturer information (Novartis Pharmaceuticals Corporation), and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.